Early returns from an ARC Advisory Group survey indicate that optimizing plant performance and eliminating process upsets are considered a critical component of asset performance management (APM) systems. Many leading companies are successfully using APM solutions—including machine learning or AI—for rotating equipment and static assets, with 27% of those also applying AI to optimize the process or production.

Today´s executives are faced with the complex challenge of maximizing profitability while meeting sustainability and corporate social responsibility (CSR) objectives. Using APM 4.0 to identify efficiencies across the organization can drive operational excellence, which in turn can lead to significant advancement of sustainability objectives.

AspenTech provides AI-enabled digital solutions that help customers optimize outcomes across the pharma value chain network using a holistic approach to digital transformation in an ever-changing world. Learn how our approach ensures the security of supply and pushes the boundaries and limits of what is possible for optimization, multiplying performance gains from digital transformation in this video.

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Learn how Pharmaceutical and Biotech Companies can use Data and AI with confidence in this brief video about our research report.

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.

If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance.

Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to ensure successful batches. The Camo solution for batch monitoring uses batch trajectory trending with smarter deviation detection to anticipate the process flow, so operators have time to act and can stay on top of production to ensure product quality and reduce waste.

The PAT (Process Analytical Technology) market is on track to more than double in size by 2023, yet many organizations have not unlocked PAT’s full potential. Watch this on-demand webinar to find out the drivers behind this growth, and how to assess and fast-track your PAT maturity.

Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these challenges by increasing saleable product through more consistent quality, higher yields and greater throughput. In addition, digitalization advances such as extensive connectivity, increased and elastic computing power, and advanced analytics have all continued to strengthen the accessibility and power of PAT to accelerate market growth.